© 2003 BMJ Publishing Group
EDITORIAL COMMENTARY
Parkinsons disease
Objective measures for the progression of Parkinsons disease
Auckland Hospital, New Zealand;
bsnow@adhb.govt.nz
Objective measure of the nigrostriatal dopaminergic deficit: evidence that SPECT does the job
Keywords: Parkinsons disease; SPECT; PET
| The first 150 words of the full text of this article appear below. |
A persisting frustration in the diagnosis, treatment, and research of Parkinsons disease is the lack of an objective measure of the nigrostriatal dopaminergic deficit. In particular, we need a tool to monitor the progress of the neuronal degeneration. This is very difficult to achieve clinically in Parkinsons disease because of the complex clinical presentation and the confounding effect of symptomatic therapy. Although PET, with markers of presynaptic dopaminergic function such as 6-fluorodopa, is an accepted measuring tool, PET is complex, expensive, cumbersome, and not widely available. The alternative is SPECT, and Winogrodzka et al on pp 2942981 of this issue provide evidence that SPECT does the job.
Winogrodzka et al took 50 patients with Parkinsons disease and performed SPECT scans 12 months apart. For their tracer, they chose [123I] ß-CIT, which binds to the presynaptic dopamine transporters. They showed an 8% decline in binding density. This matches
Relevant Article
- [123I]ß-CIT SPECT is a useful method for monitoring dopaminergic degeneration in early stage Parkinsons disease
- A Winogrodzka, P Bergmans, J Booij, E A van Royen, J C Stoof, and E C Wolters
J. Neurol. Neurosurg. Psychiatry 2003 74: 294-298.[Abstract] [Full Text] [PDF]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
